Abstract
Objective: We investigated the impact of antenatal diagnosis of fetal growth restriction (FGR) on the risks of mortality and morbidity for very preterm infants given actual birthweight percentiles.Methods: Data on 4608 live born infants 24-31 weeks of gestational age (GA) in 10 European regions in 2003 were used to compare in-hospital mortality, bronchopulmonary dysplasia (BPD) and severe neurological morbidity by birthweight percentiles and antenatal diagnosis of FGR. Other covariates were GA, sex, multiplicity, maternal complications, antenatal corticosteroids, birth in a level III center and region.Results: Sixteen percent (n = 728) of all infants and 72%, 30% and 6%, respectively, of those with birthweight percentiles
| Original language | English |
|---|---|
| Pages (from-to) | 596-601 |
| Number of pages | 6 |
| Journal | Journal of Maternal-Fetal and Neonatal Medicine |
| Volume | 29 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Feb 16 2016 |
Keywords
- Birthweight percentile
- bronchopulmonary dysplasia
- fetal growth restriction
- in-hospital mortality
- preterm infants
- severe neurological morbidity
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Obstetrics and Gynaecology
Fingerprint Dive into the research topics of 'Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort'. Together they form a unique fingerprint.
Cite this
El Ayoubi, M., Jarreau, P. H., Van Reempts, P., Cuttini, M., Kaminski, M., & Zeitlin, J. (2016). Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort. Journal of Maternal-Fetal and Neonatal Medicine, 29(4), 596-601. https://doi.org/10.3109/14767058.2015.1012062